series-a
Stage
1
Investors
About
MatchBio develops enhanced CAR-T cell therapies with improved sensitivity and specificity to reduce cancer relapses and expand treatment options.
Explore MatchBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.